Peterson, L. M., Kurland, B. F., Schubert, E. K., Link, J. M., Gadi, V. K., Specht, J. M., . . . Linden, H. M. (2014). A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC). Molecular Imaging & Biology, 16(3), 431-441.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Peterson, Lanell M., et al. "A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)."
Molecular Imaging & Biology 16, no. 3 (2014): 431-441.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Peterson, Lanell M., et al. "A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)."
Molecular Imaging & Biology, vol. 16, no. 3, 2014, pp. 431-441.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.